Sho Nishikawa

Analytical and Clinical validation of rapid chemiluminescence enzyme immunoassay for urinary thioredoxin, an oxidative stress-dependent early biomarker of acute kidney injury.

J. Yodoi, M. Iwano, K. Kasuno, 2020, Clinica chimica acta; international journal of clinical chemistry.

AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis via HDAC inhibition

M. Iwano, T. Yazawa, T. Taniguchi, 2020, Therapeutic advances in medical oncology.

Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways.

I. Kimura, M. Iwano, H. Kimura, 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells.

M. Iwano, T. Yazawa, T. Taniguchi, 2019, Journal of pharmacological sciences.

Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine

H. Naiki, M. Iwano, K. Kasuno, 2022, CEN Case Reports.

Preemptive HLA Antibody Screening Prior to Episodic Transplant Renal Biopsy Enables Early Diagnosis and Therapeutic Response in Asymptomatic Chronically Active Antibody-Related Rejection: A Case Report.

M. Iwano, K. Kasuno, H. Kimura, 2020, Transplantation proceedings.

Feasibility of Renal Blood Flow Measurement Using 64Cu-ATSM PET/MRI: A Quantitative PET and MRI Study

H. Okazawa, T. Tsujikawa, K. Kasuno, 2023, Diagnostics.